Biotech

Biotechnology in Countries Starting with “I” – Part 13: Israel

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In all candor, I had no long-term intentions in February 2013 when I started this irregular series tracking biotechnology in countries startin ...

Upcoming Talk: Finding and Evaluating BioPharmaceutical Market Entry Opportunities

I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities at the 13th Annual Pharma Resource Planning & Portfolio Management in Philadelphia, PA on February 6th, 2020. You can… The post Upcoming Talk: Finding and Evaluating BioPharmaceutical Market Entry Opportunities appeared ...

The effect of patent expiration on sales of branded competitor drugs in a therapeutic class

DrugPatentWatch was used in a recent research study on branded drug sales following generic entry. In this paper, authors Jeffrey Fujimoto, Daniel M Tien, Sophie Snyder, Jeppe A Hertz, and… The post The effect of patent expiration on sales of branded competitor drugs in a therapeutic class appear ...

Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares

Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares Original press release here VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the ...

Appili Therapeutics Names Dr. Armand Balboni as Chief Executive Officer

Appili Therapeutics Names Dr. Armand Balboni as Chief Executive Officer Original press release here HALIFAX, Nova Scotia, December 2, 2019 – Appili Therapeutics Inc. (TSXV: APLI) (the “Company” or “Appili”), a clinical stage biopharmaceutical company developing anti-infective drug and ...

Q3 2019 Share Price Performance

Q3 2019 Share Price Performance Healthcare Stocks – Choppy Stalling Pattern Continues In this blog post, the Bloom Burton equity research team summarizes the performance of the Canadian healthcare sector during 3Q-2019, and provides commentary on select stock movements and overall market trends. ...

Triumvira Immunologics Announces Fast Track Designation for Its First TAC T-Cell Therapeutic Product Candidate: TAC01-CD19

Triumvira Immunologics Announces Fast Track Designation for Its First TAC T-Cell Therapeutic Product Candidate: TAC01-CD19 Original press release here Designation Confirms Significant Unmet Need Remains in DLBCLNovember 07, 2019 07:00 AM Eastern Standard Time AUSTIN, Texas & HAMILTON, Ontario–(BU ...

2020 could be a breakout year for Tetra Bio-Pharma, says Paradigm Capital

Cannabis biopharmaceutical company Tetra Bio-Pharma (Tetra Bio-Pharma Stock Quote, Chart, News TSXV:TBP) is setting up for a big year in 2020, according to Paradigm Capital analyst Corey Hammill, who reviewed the company’s latest news release in an update to clients on Tuesday. There’s no way o ...

MindBeacon Group announces Series A follow-on investment round led by Green Shield Canada has exceeded $18 million

MindBeacon Group announces Series A follow-on investment round led by Green Shield Canada has exceeded $18 million Original press release here Investment will accelerate the company’s entrance into new markets and dramatic expansion of its digital mental healthcare platform to extend SaaS capacit ...

Poul Sorensen Receives the 2019 Bloom Burton Award

Poul Sorensen Receives the 2019 Bloom Burton Award September 30, 2019 TORONTO–(BUSINESS WIRE) — Bloom Burton & Co. (“Bloom Burton”) is pleased to announce Dr. Poul Sorensen as the recipient of the 2019 Bloom Burton Award. Dr. Sorensen is a Distinguished Scientist at the BC Cancer Agency and ...